← Open Payments lookup

MATTHEW GATLIN: Open Payments

NPI 1245552140 · SUPERIOR, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$194 in 12 payments from 7 companies in 2025. Trend: 2023 $465 · 2024 $862 · 2025 $194

Food & beverage: $194
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.3$54
Novo Nordisk Inc3$44
ABBVIE INC.2$37
Axsome Therapeutics, Inc.1$17
Lundbeck LLC1$15
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$14
Amgen Inc.1$14

Products named: REXULTI, Ozempic, VRAYLAR, Auvelity, CAPLYTA, MAVYRET, EVENITY.

Industry payments across NE — which companies pay providers there.